SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-111662
Filing Date
2021-08-31
Accepted
2021-08-31 17:02:52
Documents
12
Period of Report
2021-05-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2126694d1_8ka.htm   iXBRL 8-K/A 26136
  Complete submission text file 0001104659-21-111662.txt   206513

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aptx-20210510.xsd EX-101.SCH 3185
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20210510_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20210510_pre.xml EX-101.PRE 22710
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2126694d1_8ka_htm.xml XML 4490
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38535 | Film No.: 211227652
SIC: 2834 Pharmaceutical Preparations